NCT06341946

Brief Summary

The aim of this study is to analyze our experience in management of malfunctioning ventriculoperitoneal shunt by using endoscopic third ventriculostomy (ETV).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 7, 2024

Completed
26 days until next milestone

First Posted

Study publicly available on registry

April 2, 2024

Completed
3 days until next milestone

Study Start

First participant enrolled

April 5, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

April 2, 2024

Status Verified

March 1, 2024

Enrollment Period

1.5 years

First QC Date

March 7, 2024

Last Update Submit

March 30, 2024

Conditions

Keywords

endoscopic third ventriculostomy

Outcome Measures

Primary Outcomes (3)

  • Glasgow Coma Scale (GCS)

    clinical symptoms improvement this Score has values between 3 and 15, 3 being the worst and 15 being the highest

    base line

  • visual analogue scale( VAS )

    clinical symptoms improvement this Score has values between 0 and 10, 0 being the best and 10 being the worst

    base line

  • visual acuity

    clinical symptoms improvement

    base line

Secondary Outcomes (1)

  • radiological CT brain and or MRI brain

    base line

Study Arms (1)

endoscopic third ventriculostomy

OTHER

endoscopic third ventriculostomy in patients with malfunctioning ventriculoperitoneal shunt

Device: Endoscopic third ventriculostomy

Interventions

role of endoscopic third ventriculostomy in management of malfunctioning ventriculoperitoneal shunt

endoscopic third ventriculostomy

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • All patients with malfunctioning VP shunt will be included in this study.

You may not qualify if:

  • Patients with contraindications for endoscopic procedure such as intracranial infection or bleeding disorders
  • Previous unsuccessful attempts of endoscopic third ventriculostomy.
  • Active infection or inflammation in the central nervous system.
  • Recent history of intracranial hemorrhage.
  • Medically unfit for surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (9)

  • Kulkarni AV, Drake JM, Kestle JR, Mallucci CL, Sgouros S, Constantini S; Canadian Pediatric Neurosurgery Study Group. Predicting who will benefit from endoscopic third ventriculostomy compared with shunt insertion in childhood hydrocephalus using the ETV Success Score. J Neurosurg Pediatr. 2010 Oct;6(4):310-5. doi: 10.3171/2010.8.PEDS103.

    PMID: 20887100BACKGROUND
  • Kulkarni AV, Riva-Cambrin J, Browd SR. Use of the ETV Success Score to explain the variation in reported endoscopic third ventriculostomy success rates among published case series of childhood hydrocephalus. J Neurosurg Pediatr. 2011 Feb;7(2):143-6. doi: 10.3171/2010.11.PEDS10296.

    PMID: 21284458BACKGROUND
  • Furtado LMF, da Costa Val Filho JA, Holliday JB, da Silva Costa J, de Matos MA, Nascimento VAM, Ramos Cavalcanti T. Endoscopic third ventriculostomy in patients with myelomeningocele after shunt failure. Childs Nerv Syst. 2020 Dec;36(12):3047-3052. doi: 10.1007/s00381-020-04596-5. Epub 2020 Apr 4.

    PMID: 32248278BACKGROUND
  • Takeshige N, Uchikado H, Nakashima D, Negoto T, Nagase S, Yoshitomi M, Sakata K, Morioka M. Endoscopic third ventriculostomy for myelomeningocele-related hydrocephalus after shunt failure: Long-term outcome in a series of 8 patients. Clin Neurol Neurosurg. 2021 Feb;201:106406. doi: 10.1016/j.clineuro.2020.106406. Epub 2020 Dec 4.

    PMID: 33341457BACKGROUND
  • Chhun V, Sacko O, Boetto S, Roux FE. Third Ventriculocisternostomy for Shunt Failure. World Neurosurg. 2015 Jun;83(6):970-5. doi: 10.1016/j.wneu.2015.01.058. Epub 2015 Mar 13.

    PMID: 25772610BACKGROUND
  • Irrinki RNNS, Bawa M, Hegde S, Chhabra R, Gupta V, Gupta SK. Functional and Radiological Parameters to Assess Outcome of Endoscopic Third Ventriculostomy in Shunt Failure Patients. J Pediatr Neurosci. 2019 Apr-Jun;14(2):65-69. doi: 10.4103/jpn.JPN_31_19.

    PMID: 31516622BACKGROUND
  • Talamonti G, Nichelatti M, Picano M, Marcati E, D'Aliberti G, Cenzato M. Endoscopic Third Ventriculostomy in Cases of Ventriculoperitoneal Shunt Malfunction: Does Shunt Duration Play a Role? World Neurosurg. 2019 Jul;127:e799-e808. doi: 10.1016/j.wneu.2019.03.268. Epub 2019 Apr 4.

    PMID: 30954740BACKGROUND
  • Boschert J, Hellwig D, Krauss JK. Endoscopic third ventriculostomy for shunt dysfunction in occlusive hydrocephalus: long-term follow up and review. J Neurosurg. 2003 May;98(5):1032-9. doi: 10.3171/jns.2003.98.5.1032.

    PMID: 12744363BACKGROUND
  • Bilginer B, Oguz KK, Akalan N. Endoscopic third ventriculostomy for malfunction in previously shunted infants. Childs Nerv Syst. 2009 Jun;25(6):683-8. doi: 10.1007/s00381-008-0779-1. Epub 2008 Dec 11.

    PMID: 19082608BACKGROUND

MeSH Terms

Conditions

Hydrocephalus

Interventions

Ventriculostomy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Cerebrospinal Fluid ShuntsAnastomosis, SurgicalSurgical Procedures, OperativeNeurosurgical Procedures

Central Study Contacts

Omar Mahmoud Abellah, M.B.B. Ch, M.Sc

CONTACT

Roshdy Abdelaziz Elkahyat, MD, Professor of Neurosurgery

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: All patients with malfunctioning VP shunt will be included in this study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer

Study Record Dates

First Submitted

March 7, 2024

First Posted

April 2, 2024

Study Start

April 5, 2024

Primary Completion

October 1, 2025

Study Completion

November 1, 2025

Last Updated

April 2, 2024

Record last verified: 2024-03